Lynk Pharmaceuticals is a clinical stage company dedicated to discovering and developing novel medicines to treat oncology, immunology and inflammatory diseases. Lynk was founded by veteran drug hunters from Pfizer, Merck and Johnson & Johnson with collectively more than several decades of rich experiences in drug discovery. Driven by a higher purpose, Lynk aims at growing into a market leader for developing innovative therapies to address unmet medical needs.

Lynk Pharmaceuticals

Angel Pharmaceuticals is a clinical stage company dedicated to discovering and developing novel medicines to treat oncology, immunology, and inflammatory diseases.

Angel Pharmaceuticals

Psivant is a clinical stage company dedicated to discovering and developing novel medicines to treat oncology, immunology, and inflammatory diseases.

Psivant

Azitra Inc. is a company focused on inflammation therapeutics.

Azitra Inc.

OBI Pharma is a company engaged in developing therapeutics for multiple diseases, including inflammation.

OBI Pharma

Lynk Pharmaceuticals is a biotechnology company focused on the discovery and development of novel treatments for cancer and inflammatory diseases. The company leverages its proprietary drug discovery platforms to target key drivers of diseases.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 16, 2024 8:14 AM	e9e1e2ab
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	1b8e936f
crunchbase profile	general
li profile	general	May 16, 2024 8:14 AM	a94f222c
translate crunchbase fundingrounds	general
peers	general
news basic	general
bundesanzeiger	filings
financials download nd	financials
private financials	financials

LYNK

COM:LYNKPHARMA

Lynk Pharmaceuticals